Cargando…

Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches

SIMPLE SUMMARY: Prostate cancer is the most common tumor in men. Although there have been many new developments in the last few years, metastatic castration resistant prostate cancer remains a deadly disease. This article provides an overview of currently approved treatment options as well as new th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Posdzich, Philip, Darr, Christopher, Hilser, Thomas, Wahl, Milan, Herrmann, Ken, Hadaschik, Boris, Grünwald, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856730/ https://www.ncbi.nlm.nih.gov/pubmed/36672410 http://dx.doi.org/10.3390/cancers15020461

Ejemplares similares

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2021)

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis
por: Fazekas, Tamás, et al.
Publicado: (2022)

The current and future role of magnetic resonance imaging in prostate cancer detection and management
por: Radtke, Jan Philipp, et al.
Publicado: (2015)

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy
por: Krafft, Ulrich, et al.
Publicado: (2021)

Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs
por: Ferretti, Simone, et al.
Publicado: (2023)

Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls
por: Darr, Christopher, et al.
Publicado: (2021)

Chronic prostatitis: current treatment options
por: Pirola, Giacomo Maria, et al.
Publicado: (2019)

Fabry Cardiomyopathy: Current Treatment and Future Options
por: Vardarli, Irfan, et al.
Publicado: (2021)

The Biomarker Potential of Caveolin-1 in Penile Cancer
por: Panic, Andrej, et al.
Publicado: (2021)

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
por: Ong, Sean, et al.
Publicado: (2021)

Current treatment options in the management of chronic prostatitis
por: Duclos, Alain Jean, et al.
Publicado: (2007)

COVID-19 research: promising tracks leading to uro-oncology
por: Tamás, Fazekas, et al.
Publicado: (2020)

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
por: Pogorzelski, Michael, et al.
Publicado: (2021)

Current Management Options in Metastatic Renal Cell Cancer
por: Gangadaran, Sittu Govindasamy Dinakaran
Publicado: (2017)

Metastatic and locally aggressive BCC: Current treatment options
por: Casey, Máire‐Caitlín, et al.
Publicado: (2021)

Correction to: COVID-19 research: promising tracks leading to uro-oncology
por: Fazekas, Tamás, et al.
Publicado: (2020)

High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
por: Széles, Ádám, et al.
Publicado: (2022)

Update on options for treatment of metastatic castration-resistant prostate cancer
por: Vishnu, Prakash, et al.
Publicado: (2010)

Treatment of Prostatic Abscess: Role of Transrectal Ultrasound Guided Needle Aspiration
por: Kuru, Timur H., et al.
Publicado: (2012)

Hydrogels for the management of second-degree burns: currently available options and future promise
por: Cook, Katherine A, et al.
Publicado: (2022)

Laser Surgery of the Prostate: A Review of the Current Options
por: McNicholas, Tom A., et al.
Publicado: (2004)

Metastatic penile carcinoma – an update on the current diagnosis and treatment options
por: Barski, Dimitri, et al.
Publicado: (2014)

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
por: Awang, Zool Hilmi, et al.
Publicado: (2018)

Virtual Biopsy: Just an AI Software or a Medical Procedure?
por: Murray, Jacob M., et al.
Publicado: (2022)

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
por: Kesch, Claudia, et al.
Publicado: (2021)

Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients
por: Sigurdson, Samantha S., et al.
Publicado: (2020)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Naseer, Faiza, et al.
Publicado: (2021)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma
por: Ferdinandus, Justin, et al.
Publicado: (2022)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
por: Staniszewska, Magdalena, et al.
Publicado: (2021)

Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from “Challenges and Chances in Prostate Cancer Research Meeting 2013”
por: Combs, Stephanie E, et al.
Publicado: (2014)

Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept
por: Dietvorst, Maria H. P., et al.
Publicado: (2013)

TURPxit or not: contemporary management options for benign prostatic obstruction
por: Herrmann, Thomas R. W., et al.
Publicado: (2021)

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
por: Gafita, Andrei, et al.
Publicado: (2022)

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
por: Eggers, Hendrik, et al.
Publicado: (2022)

Narcolepsy: current treatment options and future approaches
por: Billiard, Michel
Publicado: (2008)

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
por: Fanti, Stefano, et al.
Publicado: (2020)

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
por: Handke, Analena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hns95j24ah50kgmvbr95p91r9o